Alixorexton

N/A

Report date: 2026/05/16 20:00:17
NME

Base Information

Drug NameAlixorexton
Drug Alias NameALKS2680ALKS-2680RDC-264177
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 2 agonists
TargetsOrexin receptor type 2
Therapy Area/IndicationsNarcolepsyIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[8
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlkermes Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlkermes PlcAlkermes Inc
Inactive CompaniesN/A
Active IndicationsNarcolepsyIdiopathic Hypersomnia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A